185 related articles for article (PubMed ID: 36674837)
1. Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis.
Wu TH; Tsai YT; Chen KY; Yap WK; Luan CW
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674837
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
Qi F; Xu Y; Zheng Y; Li X; Gao Y
Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
[TBL] [Abstract][Full Text] [Related]
4. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer.
Hanai N; Sawabe M; Kimura T; Suzuki H; Ozawa T; Hirakawa H; Fukuda Y; Hasegawa Y
Oncotarget; 2018 Dec; 9(97):37008-37016. PubMed ID: 30651931
[TBL] [Abstract][Full Text] [Related]
5. Utility of modified Glasgow prognostic score for head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Luan CW; Kuo LT; Wang YT; Liao CT; Kang CJ; Lee YC; Chen KY; Lai CH; Tsai YH; Huang EI; Tsai MS; Hsu CM; Chang GH; Tsai YT
Head Neck; 2023 Jul; 45(7):1856-1867. PubMed ID: 37161915
[TBL] [Abstract][Full Text] [Related]
6. Utility of the Modified and High-Sensitivity Modified Glasgow Prognostic Scores for Hypopharyngeal Squamous Cell Carcinoma.
Iuchi H; Ohori J; Matsuzaki H; Kiyama S; Yamashita M
OTO Open; 2021; 5(4):2473974X211067423. PubMed ID: 34950840
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Pretreatment Glasgow Prognostic Score/Modified Glasgow Prognostic Score in Ovarian Cancer: A Systematic Review and Meta-Analysis.
Xu S; Song L; Liu X
Nutr Cancer; 2022; 74(6):1968-1975. PubMed ID: 34549675
[TBL] [Abstract][Full Text] [Related]
8. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis.
Nie D; Zhang L; Wang C; Guo Q; Mao X
Arch Gynecol Obstet; 2020 Jun; 301(6):1543-1551. PubMed ID: 32409927
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Utility of the Modified Glasgow Prognostic Score in Urothelial Carcinoma: Outcomes from a Pooled Analysis.
Tan D; Li J; Lin T; Tan P; Zhang J; Xiong Q; Jiang J; Li Y; Zhang P; Wei Q
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362488
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.
Jin J; Hu K; Zhou Y; Li W
PLoS One; 2017; 12(9):e0184412. PubMed ID: 28886134
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis.
Zhou Y; Liu Z; Cheng Y; Li J; Fu W
J Gastrointest Surg; 2024 Apr; 28(4):559-565. PubMed ID: 38583910
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis.
Fu W; Wang K; Yan S; Wang X; Tang B; Chang J; Wang R; Wu T
Dose Response; 2020; 18(3):1559325820942065. PubMed ID: 32821253
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer.
Zhang Y; Chen S; Chen H; Li W
Cancer Med; 2023 Jan; 12(1):38-48. PubMed ID: 35702873
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Role of High-Sensitivity Modified Glasgow Prognostic Score for Patients With Operated Oral Cavity Cancer: A Retrospective Study.
Tsai YT; Fang KH; Hsu CM; Lai CH; Chang SW; Huang EI; Tsai MS; Chang GH; Luan CW
Front Oncol; 2022; 12():825967. PubMed ID: 35242712
[TBL] [Abstract][Full Text] [Related]
16. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
[No Abstract] [Full Text] [Related]
17. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score.
Hirahara N; Matsubara T; Kaji S; Kawabata Y; Hyakudomi R; Yamamoto T; Uchida Y; Ishitobi K; Takai K; Tajima Y
Oncotarget; 2020 Nov; 11(45):4169-4177. PubMed ID: 33227100
[TBL] [Abstract][Full Text] [Related]
18. Predicting outcomes of Lung Cancer using the modified glasgow prognostic score: A systematic review and meta-analysis.
Min Y; Li X; Chen H; Xu Y; Lan G
Pak J Med Sci; 2024; 40(3Part-II):534-543. PubMed ID: 38356845
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis.
Zhang H; Ren D; Jin X; Wu H
Cancer Cell Int; 2020; 20():462. PubMed ID: 32982584
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis.
Xie Y; Li H; Hu Y
Medicine (Baltimore); 2023 Nov; 102(45):e35962. PubMed ID: 37960803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
